retatrutide trade name The Dosage Chart Retatrutide vs Mounjaro: triple agonist

For those beginning either drug, monitoring food intake, body weight, and activity levels can indicate whats working or needs adjustment

In the SURPASS clinical trial program, patients treated with Tirzepatide experienced: HbA1c reductions up to 2.5% Weight loss up to 22.5% of body weight in some trials These numbers surpass those seen in many existing diabetes medications and even some weight loss drugs

GLP-1 medications may or may not be covered

These medications are administered via subcutaneous injection, typically weekly for semaglutide and dulaglutide, or daily for liraglutide

Take the GLP-1 Optimizer Quick Quiz to find out: Personalized Results: Is it likely your body is currently struggling with insufficient GLP-1 production